Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
University of Rochester
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Emory University
NYU Langone Health
Georgetown University
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Miami
University of California, Davis
Brown University
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Chicago
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Thomas Jefferson University
Case Comprehensive Cancer Center
Thomas Jefferson University
Yale University
Herlev Hospital
Providence Health & Services
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
University of California, San Diego
Duke University
City of Hope Medical Center
Mayo Clinic
City of Hope Medical Center
University of Chicago
NRG Oncology
University of Colorado, Denver
Grupo Español Multidisciplinar de Melanoma
Thomas Jefferson University
University of Pittsburgh
Thomas Jefferson University
Dana-Farber Cancer Institute
Emory University